SOCS3 and asthma: These findings suggest that while SOCS3 supports Th2 polarization and effector function, its overexpression in asthma may exacerbate eosinophil-driven inflammation, indicating that fine-tuning rather than complete suppression of SOCS3 (to avoid massive degranulation) may offer therapeutic benefits [95].